Explore how integrative multi-omics drug sensitivity data can improve your drug development.
Explore how integrative multi-omics drug sensitivity data can improve your drug development.
The Stanford University Cancer Center and the MDS Foundation are proud to bring you this complimentary webinar presented by Stanford’s Dr. Michael Spinner, post-doctoral medical fellow, oncology, and moderated by the MDS Foundation’s Sandra Kurtin, Ph.D., ANP-C, AOCN.